ONKORD
Live / Registered — Registered — Section 71 accepted (as of 03 Jul 2023)
What this means for you
Registered since 14 Nov 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79208841
- Registration number
- 5332246
- Mark type
- Stylized text
- Filed
- 30 Mar 2017
- Published for opposition
- 29 Aug 2017
- Registered
- 14 Nov 2017
- Attorney of record
- Michael M. Morris
Goods and services
- Class 005 — Pharmaceuticals: Cell products for treating cancer, namely, cells for medical use in the field of immuno-oncology
Owner
- Glycostem Therapeutics B.V., Oss, NL
- IPD Therapeutics B.V., NL
- IPD Therapeutics B.V., NL
Prosecution history
- 08 Dec 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 03 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 03 Jul 2023 — REGISTERED-SEC.71 ACCEPTED
- 03 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Dec 2022 — TEAS SECTION 71 RECEIVED
- 14 Nov 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 24 May 2018 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 13 Apr 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Feb 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Feb 2018 — FINAL DISPOSITION PROCESSED
- 14 Feb 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Aug 2017 — PUBLISHED FOR OPPOSITION
- 09 Aug 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED